Product Details
Sitagliptin for Tablets BP
These film-coated tablets meet British Pharmacopoeia standards, delivering dependable blood glucose control. Physicians widely prescribe Sitagliptin to manage type 2 diabetes, either alone or alongside other antidiabetic agents.
Sitagliptin BP (100 mg) is a DPP-4 inhibitor that increases incretin levels, boosting insulin release and suppressing glucagon secretion in response to meals. As a result, it helps lower blood glucose without the higher hypoglycemia risk seen with some other antidiabetic classes. Because of this favorable safety profile, physicians often prescribe it as monotherapy or in combination with metformin and other agents. Therefore, doctors rely on it across hospitals, diabetology clinics, and general outpatient settings.
Key Features
- Meets BP (British Pharmacopoeia) standards for consistent quality
- Delivers targeted DPP-4 inhibition for effective glycaemic control
- Ensures accurate, validated dosing in every batch
- Suits pharmacy, hospital, and institutional supply needs
- Follows GMP-compliant manufacturing processes
- Supports flexible use as monotherapy or alongside other antidiabetics